@article{ref1,
title="Driving impairment following vaporization of cannabis",
journal="JAMA journal of the American Medical Association",
year="2021",
author="Downey, Luke A. and Hayley, Amie C.",
volume="325",
number="12",
pages="e1225-e1225",
abstract="To the Editor We read with interest the recent findings reported by Dr Arkell and colleagues1 concerning the effect of vaporized Δ9-tetrahydrocannabinol (THC)-dominant and THC/cannabidiol (CBD)-equivalent cannabis on on-road driving performance.   Impairment noted in both the THC-dominant cannabis and THC/CBD-equivalent cannabis was within the expected range, evident up to 4 hours after the dose and accompanied by a reduction in confidence to drive in both THC groups. Arkell et al2 recently reported that more than one-third of Australian patients who use analogous medicinal cannabis products admit to having driven a vehicle within 3 hours of consuming cannabis while citing a low perception of risk.  Keywords: Cannabis impaired driving <p /> <p>Language: en</p>",
language="en",
issn="0098-7484",
doi="10.1001/jama.2021.0451",
url="http://dx.doi.org/10.1001/jama.2021.0451"
}